Chimeric Therapeutics Ltd Ordinary Shares
Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells.
Latest CHM News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News